Aspire Biopharma logo

Aspire Biopharma

ASBP | NASDAQ
Chart Builder DCF Calculator
$8.06
-$0.35 (-4.16%)
At close: Nov 16, 2026, 4:00 PM ET
$8.30
+$0.24 (+2.98%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.16%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
29.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #813/1021 (Top 80%)

Key Statistics

Market Data

Market Cap $929.9K
1D Range
8.06 8.54
52W Range
4.65 170.40

Valuation (TTM)

PE -1
PB 0.08
EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A
Forward PEG -0.01
Price Target $0.00
Loading financial charts...

Profile

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship ...

Sector Healthcare
Employees 2
IPO Date Feb 20, 2025
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.